Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Chinese Renal Transplant Recipients: A Prospective Randomized Controlled Study.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Tacrolimus (Primary) ; Herbal medicines; Mycophenolate mofetil; Prednisone
Indications Renal transplant rejection
Focus Pharmacogenomic; Pharmacokinetics

09 Jun 2011 Mycophenolate mofetil,prednisone, cost analysis and drug interactions added as descriptors and PEC added as therapeutic area
09 Jun 2011 Results published in the European Journal of Clinical Pharmacology.
28 Jul 2010 Biomarkers information updated

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com